Artelo Biosciences
ARTL
7 hedge funds and large institutions have $121K invested in Artelo Biosciences in 2025 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, reducing their positions, and 4 closing their positions.
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
17% more funds holding
Funds holding: 6 → 7 (+1)
3.24% more ownership
Funds ownership: 1.64% → 4.88% (+3.2%)
20% less capital invested
Capital invested by funds: $152K → $121K (-$31.1K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$86.4K |
| 2 |
Two Sigma Investments
New York
|
+$53.5K |
| 3 |
VF
Virtu Financial
New York
|
+$43.6K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$29.5K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.89K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DS
DRW Securities
Chicago,
Illinois
|
-$78.9K |
| 2 |
Morgan Stanley
New York
|
-$5.05K |
| 3 |
Citigroup
New York
|
-$2.19K |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$138 |
ARTL Hedge Fund Activity: Q4 2025 in Review
7 of the 8,280 institutional investors tracked by Wall St. Rank reported a position in Artelo Biosciences (ARTL) for Q4 2025, worth a combined $121K — down 20% from $152K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new ARTL positions and 4 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, adding an estimated $86.4K. The largest seller was DRW Securities, exiting entirely with an estimated $78.9K sold.
- 7 institutional investors held Artelo Biosciences (ARTL) as of Q4 2025, up from 6 in Q3 2025.
- Funds reported $121K of Artelo Biosciences stock for Q4 2025, down 20% quarter-over-quarter.
- 5 funds opened new Artelo Biosciences positions in Q4 2025 and 4 closed out, a net change of +1 holder.
- The largest Artelo Biosciences buyer in Q4 2025 was UBS Group, an estimated $86.4K added.
- The largest Artelo Biosciences seller in Q4 2025 was DRW Securities, an estimated $78.9K sold.
Based on aggregated 13F filings for Q4 2025.